MiMedx Group Inc. (MDXG) - NASDAQ
From other sites
Company Description
MiMedx Group, Inc. developes, manufactures and markets patent protected regenerative biomaterial products and bioimplants processed from human amniotic membrane. Its biomaterial platform technologies include AmnioFix and EpiFix, its tissue technologies processed from human amniotic membrane that... More
Sector: Healthcare
Industry: Medical Appliances & Equipment
Country: United States